References
1. Fraunfelder FT, Randall JA. Minocycline-induced scleral pigmentation.Ophthalmology. 1997;104(6):936-938.
2. Angeloni VL, Salasche SJ, Ortiz R. Nail, skin, and scleral pigmentation induced by minocycline. Cutis. 1987;40(3):229-233.
3. Rumbak MJ, Pitcock JA, Palmieri GM, Robertson JT. Black bones following long-term minocycline treatment. Arch Pathol Lab Med.1991;115(9):939-941.
4. Butler JM, Marks R, Sutherland R. Cutaneous and cardiac valvular pigmentation with minocycline. Clin Exp Dermatol.1985;10(5):432-437.
5. Argenyi ZB, Finelli L, Bergfeld WF, et al. Minocycline-related cutaneous hyperpigmentation as demonstrated by light microscopy, electron microscopy and X-ray energy spectroscopy. J Cutan Pathol. 1987;14(3):176-180.
6. Landas SK, Schelper RL, Tio FO, Turner JW, Moore KC, Bennett-Gray J. Black thyroid syndrome: exaggeration of a normal process? Am J Clin Pathol. 1986;85(4):411-418.
7. Suwannarat P, Phornphutkul C, Bernardini I, Turner M, Gahl WA. Minocycline-induced hyperpigmentation masquerading as alkaptonuria in individuals with joint pain. Arthritis and rheumatism.2004;50(11):3698-3701.
8. Mehrany K, Kist JM, Ahmed DD, Gibson LE. Minocycline-induced cutaneous pigmentation. Int J Dermatol. 2003;42(7):551-552.
9. Yamaguchi S, Koda N, Ohashi T. Diagnosis of alkaptonuria by NMR urinalysis: rapid qualitative and quantitative analysis of homogentisic acid. The Tohoku journal of experimental medicine.1986;150(2):227-228.
10. Aquaron R. Alkaptonuria: a very rare metabolic disorder.Indian journal of biochemistry & biophysics. 2013;50(5):339-344.
Figure Legends:
Figure 1
A: Blue pinna, B: Blue discoloration of mastoid bone
Figure 2
A: Blue tympanic membrane, B: Blue discoloration of the sclera, C: Blue Pinna, D: Blue discoloration of nail beds, E: Blue discoloration of teeth, F: Urine before (left) and after (right) oxidation, much darker in color.